Renal outcomes after chimeric antigen receptor T-cell therapy: a single-center perspective

Nephrol Dial Transplant. 2022 Aug 22;37(9):1777-1779. doi: 10.1093/ndt/gfac048.

Authors

Rehan Ansari¹, Paolo Caimi², Ho Jun Lee¹, Zhengyi Chen³, Arash Rashidi¹

Affiliations

¹ Division of Nephrology and Hypertension, University Hospitals Cleveland Medical Center, Cleveland, USA.
² Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, USA.
³ Department of Population and Quantitative Health Science, Case Western Reserve University, Cleveland, USA.

PMID: 35218198
DOI: 10.1093/ndt/gfac048

No abstract available

Publication types

Letter

MeSH terms

Cell- and Tissue-Based Therapy
Humans
Immunotherapy, Adoptive / adverse effects
Receptors, Chimeric Antigen*

Substances

Receptors, Chimeric Antigen